J2789 — Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
J2789 is a HCPCS Level II code for riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J2789
- Long descriptor
- Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
- Short descriptor
- Riboflavin epioxa/hd<=2ml
- Added
- July 1, 2026
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J2789
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2789 is not quite right, the correct code is very often within a few positions of it.
- J2780Injection, ranitidine hydrochloride, 25 mgterminated
- J2781Injection, pegcetacoplan, intravitreal, 1 mg
- J2782Injection, avacincaptad pegol, 0.1 mg
- J2783Injection, rasburicase, 0.5 mg
- J2785Injection, regadenoson, 0.1 mg
- J2786Injection, reslizumab, 1 mg
- J2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
- J2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
- J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
- J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
- J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
- J2793Injection, rilonacept, 1 mg
- J2794Injection, risperidone (risperdal consta), 0.5 mg
- J2795Injection, ropivacaine hydrochloride, 1 mg
- J2796Injection, romiplostim, 10 microgramsterminated
- J2797Injection, rolapitant, 0.5 mg
Questions about J2789
What is HCPCS code J2789?
J2789 is a HCPCS Level II code for riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2789?
The CMS HCPCS file marks J2789 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J2789 paid under the physician fee schedule?
J2789 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).